Background/Aims: The mineral-dust-induced gene mdig is a lung-cancer-associated oncogene. The focus of this study is to evaluate the expression status of mdig in lung cancer and to assess its influence in predicting the patient’s overall survival. Methods: Using high-density tissue microarrays and clinical samples of synchronous multiple primary lung cancer (SMPLC), we investigated the expression of mdig through immunohistochemistry and utilized the open-access lung cancer patient databases containing genomic and transcriptomic data from the UCSC Xena and TCGA web platforms to determine the prognostic values of mdig expression status among different subtypes of lung cancer. Results: mdig is upregulated in smokers and in lung squamous cell carcinoma. High mdig expression predicted poor overall survival in lung squamous cell carcinoma and female smokers. Among tumor tissues from SMPLC patients, we not only unraveled the highest positive rate of mdig expression, but also revealed a unique cytoplasmic, rather than nuclear localization of mdig protein. Furthermore, by inspecting some pathological but not cancerous lung tissues, we believe that mdig is required for the transformation of non-cancerous lung cells to the fully-fledged cancer cells. Conclusion: These data suggested that mdig is involved in various stages of lung carcinogenesis, possibly through the epigenetic regulation on some critical cancer-associated genes, and increased mdig expression is an important prognostic factor for some types of lung cancer.
Cysts mark the early stage of metastatic tumor development in non-small cell lung cancer Cysts mark the early stage of metastatic tumor development in non-small cell lung cancer
9 July 2026 in Journal of Evidence-Based Integrative Medicine
Complementary and alternative medicine (CAM) practices have been widely adopted for thousands of years in the Eastern world. Integration of such approaches into the conventional medicine model has been limited, however, and there continues to be a paucity of data describing the extent of CAM usage in the US. The purpose of this investigation was to derive nationally-based estimates of CAM utilization among a large sample of adults who completed the 2022 National Health Interview Survey (NHIS). In this cross-sectional analysis, chi-squared tests and multivariate logistic regression models were used to identify factors associated with CAM use. Among 27 651 adults completing the survey, approximately 37% reported participating in at least one CAM activity in the past 12 months. CAM users were more likely to be of younger age, female sex, have obtained higher levels of education, have increased anxiety and report having better overall health. Meditation (18%), yoga (15%), chiropractic care (11%), and massage therapy (11%) were the most frequently reported modalities, while fewer than 5% of respondents visited an acupuncturist or naturopath or participated in art or music therapy. The main reason for CAM utilization was to improve overall health. Findings from this study indicate that approximately one-third of US adults engage in some form of CAM activity and that better health outcomes were associated with these practices. Additional research is needed to better understand the barriers and facilitators of CAM use and to further qualify which factors may influence the decision to (or not to) engage in such practices.
BackgroundWe have identified an environmentally inducible gene, mdig that predicted the overall survival in breast cancer patients. We showed that mdig regulated breast cancer cell growth, motility and invasion partially through DNA and histone methylation. However, we have lacked a comprehensive analysis of the proteomic profile of mdig in triple negative breast cancer cells. MethodsWe applied mass spectrometry to acquire global proteomic and post translational modification analysis for triple negative breast cancer cells MDA-MB-231 that had mdig deleted via CRISPR Cas 9 gene editing. Using label-free bottom up quantitative proteomics, we compared wildtype control (WT) and mdig knockout (KO) MDA-MB-231 cells and identified the proteins and pathways that are significantly altered with mdig deletion. The Ingenuity Pathway Analysis (IPA) platform was further used to explore the signaling pathway networks incorporating differentially expressed proteins. Results904 differentially expressed (p < 0.005) proteins were identified in MDA-MB-231 cells that had mdig deletion. Approximately 30 pathways and networks linked to the pathogenicity of breast cancer and populated by the differentially expressed proteins were either activated or inhibited. IPA established that the differentially expressed proteins have relevant biological actions in cell growth, motility and malignancy. This analysis provides a rich source of potential candidate therapeutic targets with potential prognostic significance in triple negative breast cancer. Data are available via ProteomeXchange with identifier PXD016688.Conclusions These data provide the first insight into protein expression patterns in breast cancer associated with a complete disruption of the mdig gene. Differentially expressed proteins between WT and KO MDA-MB-231 triple negative breast cancer cells provide substantial information regarding key proteins, biological process and pathways that are modulated by mdig and contribute to breast cancer tumorigenicity and invasiveness. Mdig modulated signaling pathways and hub molecules provide novel targets for the development of treatment strategies and breast cancer therapies.